ACCC Statement on Rise of Cancer Mortality and Advanced Cancer Rates in 2020
Randall A. Oyer, MD
Randall A. Oyer, MD, President of the Association of Community Cancer Centers (ACCC), released a statement regarding the rise in mortality rates of specific cancers and the rise in the occurrence of advanced metastatic cancers in 2020. New research presented at the United European Gastroenterology Week Virtual 2020 showed a significantly higher rate of mortality (11.9%) in colorectal cancer as a direct result of the global COVID-19 pandemic. Additionally, GenesisCare, which provides oncology care worldwide, released data showing an increase in the number of patients with late-stage cancer diagnoses.
According to the study, the number of women presenting with stage III or IV breast cancer increased to 18.1% from the previous year’s figure of 12.1%. In addition, the percentage of patients presenting with stage III or IV lung cancer increased to 38% from the figure of 32.6% from the previous year.
After so many years of a steady decrease in both mortality and late-stage diagnosis rates, the health-care community understood the catastrophic impact that COVID-19 might have on screenings and diagnoses. The rise in advanced metastatic rates and the change in death rates indicated by these data represent a warning to all sectors of health care to do whatever it takes to encourage screenings and reassure patients.
Improving Outreach
The ACCC has worked with its membership to quickly adapt to changes in the delivery of quality care to patients. The organization shared its ideas on how cancer and medical professionals can employ creative techniques to improve cancer screening, such as the following:
- Use of mobile medical clinics to deliver cancer screenings
- Development and dissemination of safety protocols directly to patients—and through social media—to show how hospitals and clinics are keeping patients safe
- Outreach and education to local media and community organizations about new measures to ensure safe screenings and the importance of not delaying regular appointments and to ask for help to distribute this information and to encourage patients to resume screenings
- Proactive outreach to patients to remind them of the need for screenings and to engage in personal conversations to allay fears, rather than waiting for patients to schedule appointments.
ACCC is also addressing the financial impact of COVID-19, which can affect patients’ decisions to delay screenings or treatment, through podcasts, curated resources, and a dedicated online community.
